245 related articles for article (PubMed ID: 33809908)
1. The Role of Endoglin in Hepatocellular Carcinoma.
Jeng KS; Sheen IS; Lin SS; Leu CM; Chang CF
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809908
[TBL] [Abstract][Full Text] [Related]
2. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy.
Kasprzak A; Adamek A
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563158
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.
Kwon YC; Sasaki R; Meyer K; Ray R
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794048
[TBL] [Abstract][Full Text] [Related]
4. Increased Serum Endoglin and Transforming Growth Factor β1 mRNA Expression and Risk of Hepatocellular Carcinoma in Cirrhotic Egyptian Patients.
Teama S; Fawzy A; Teama S; Helal A; Drwish AD; Elbaz T; Desouky E
Asian Pac J Cancer Prev; 2016; 17(5):2429-34. PubMed ID: 27268609
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium.
Benetti A; Berenzi A; Gambarotti M; Garrafa E; Gelati M; Dessy E; Portolani N; Piardi T; Giulini SM; Caruso A; Invernici G; Parati EA; Nicosia R; Alessandri G
Cancer Res; 2008 Oct; 68(20):8626-34. PubMed ID: 18922939
[TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
7. Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma.
Plissonnier ML; Herzog K; Levrero M; Zeisel MB
Viruses; 2018 Oct; 10(11):. PubMed ID: 30380697
[TBL] [Abstract][Full Text] [Related]
8. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of hepatocellular carcinoma contributes to cancer progression.
Jeng KS; Chang CF; Jeng WJ; Sheen IS; Jeng CJ
Crit Rev Oncol Hematol; 2015 Jun; 94(3):337-47. PubMed ID: 25680939
[TBL] [Abstract][Full Text] [Related]
10. EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.
Gu F; Yuan S; Liu L; Zhu P; Yang Y; Pan Z; Zhou W
J Cell Mol Med; 2019 Jun; 23(6):4208-4216. PubMed ID: 30957411
[TBL] [Abstract][Full Text] [Related]
11. Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma.
Meng J; Liu Y; Han J; Tan Q; Chen S; Qiao K; Zhou H; Sun T; Yang C
Mol Cancer; 2017 Mar; 16(1):72. PubMed ID: 28359326
[TBL] [Abstract][Full Text] [Related]
12. Endoglin interacts with VEGFR2 to promote angiogenesis.
Tian H; Huang JJ; Golzio C; Gao X; Hector-Greene M; Katsanis N; Blobe GC
FASEB J; 2018 Jun; 32(6):2934-2949. PubMed ID: 29401587
[TBL] [Abstract][Full Text] [Related]
13. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.
Yu D; Zhuang L; Sun X; Chen J; Yao Y; Meng K; Ding Y
BMC Cancer; 2007 Jul; 7():122. PubMed ID: 17608955
[TBL] [Abstract][Full Text] [Related]
14. Endoglin Targeting: Lessons Learned and Questions That Remain.
Liu Y; Paauwe M; Nixon AB; Hawinkels LJAC
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375670
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features.
Ribeiro OD; Canedo NH; Pannain VL
Clinics (Sao Paulo); 2016 Nov; 71(11):639-643. PubMed ID: 27982164
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
Ho JW; Poon RT; Sun CK; Xue WC; Fan ST
World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211
[TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB-EGF Expression and Proteolytic Cleavage.
Dong ZR; Sun D; Yang YF; Zhou W; Wu R; Wang XW; Shi K; Yan YC; Yan LJ; Yao CY; Chen ZQ; Zhi XT; Li T
Hepatology; 2020 Sep; 72(3):923-939. PubMed ID: 31867749
[TBL] [Abstract][Full Text] [Related]
20. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
Gallardo-Vara E; Tual-Chalot S; Botella LM; Arthur HM; Bernabeu C
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
